FibroBiologics Files 2023 Form 10-K Annual Report

HOUSTON, Feb. 29, 2024 /PRNewswire/ — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”) a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and…